VAERS Reports T9N35

VAERS 1625430

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge T9N35

schwer

Staat: OK
Alter: 51,0
Geschlecht: F
Eingang: 23.08.2021
Impfdatum: 08.11.2019
Beginn: 21.11.2019
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Chronic inflammatory demyelinating polyradiculoneuropathy Electromyogram Guillain-Barre syndrome Immunoglobulin therapy Lumbar puncture Magnetic resonance imaging Paralysis

Symptomtext

I began symptoms November 21st 2019 which slowly progressed to being paralyzed by Jan 27th 2020 I was diagnosed with GBS and treated with IVIG, sent to rehab got worse. Readmitted to another hospital and diagnosis changed to CIDP. Still in treatment to this day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: 35,0
Labordaten: MRI Jan. 27th 2020 , Lumbar puncture Jan 29th 2020, EMG Mar. 12th 2020, follow up EMG Feb 5th 2021
Aktuelle Erkrankungen: Lumbar fusion Oct. 1st 2019
Vorgeschichte: Essential hypertension, depression, PCOS, GAD, degenerative dick
Andere Medikamente: Lisinopril, Pravastatin, Sertraline, Tramadol, Spironolactone
Allergien: none
Vorherige Impfungen: -

VAERS 1456587

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge T9N35

gering

Staat: -
Alter: -
Geschlecht: F
Eingang: 08.07.2021
Impfdatum: 01.11.2019
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hypersensitivity Obstructive airways disorder

Symptomtext

she had a severe allergic reaction to it; with her airways blocked; This case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a female patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2019-2020 season) (batch number T9N35, expiry date 30th June 2020) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. In November 2019, the patient received Fluarix Tetra 2019-2020 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, less than 2 years after receiving Fluarix Tetra 2019-2020 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced allergic reaction and airways obstruction. On an unknown date, the outcome of the allergic reaction and airways obstruction were recovered/resolved. It was unknown if the reporter considered the allergic reaction and airways obstruction to be related to Fluarix Tetra 2019-2020 season and Fluarix Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The case was reported by patient herself. The age at vaccination was not reported. The patient experienced severe allergic reaction and her airways was blocked. At the time of reporting, the patient was recovered from reactions. The reporter did not consent nor declined follow up. No further information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypersensitivity
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -